Referral Traffic From Social Media Platforms A Key Factor

DALLAS, Feb. 4, 2020 /PRNewswire/ — Kali-Extracts, Inc. (Kali, Inc. dba/Kali-Extracts, Inc.) (USOTC: KALY) (‘KALY’) today announced entering into letter of intent (LOI) under which KALY could receive a $20 million investment to fund its Cannabis Biopharmaceutical Technology. KALY has a U.S. Patented Cannabis Extraction Process it uses to produce proprietary formulations for the treatment of various medical conditions. The proposed investment values KALY’s cannabis biopharmaceutical technology at $50 million. The confidential terms of the LOI target a planned $5 million first tranche within ninety days.

NEW YORK, Feb. 4, 2020 /PRNewswire/ — Like so many have predicted, the CBD market continues to grow and gain traction at an unprecedented rate. While the use of sublingual CBD (which involves placing oil droplets below the tongue) remains a popular form of consumption, market analysis shows that CBD gummies are now more widely used than ever before.

AcesoHemp introduces two new topical product segments in response to consumer demand, further expanding its presence in the booming CBD topicals category.

/NOT FOR DISSEMINATION IN THE UNITED STATES OR FOR DISTRIBUTION TO UNITED STATES WIRE SERVICES/

Research will identify and analyse pharmacological, agricultural and genetic characteristics of 240 cannabis varieties for therapeutic purposes, such as refractory epilepsy

NYSE | TSX : ACB

VANCOUVER, British Columbia, Feb. 1, 2020 /PRNewswire/ — MYM Nutraceuticals Inc., (CSE: MYM) (OTC: MYMMF) (CSE: MYM.CN) (MYM.CN) (“MYM” or “The Company”) is pleased to announce its subsidiary, Sublime Culture Inc., has received a cultivation license from Health Canada to produce cannabis at its indoor facility located in Laval, Quebec.